Select the model structures to use in the IVI-RA individual patient simulation.
select_model_structures(tx_ihaq = "acr-haq", tx_iswitch = "acr-switch", cdmards_haq_model = "lcgm", ttd_cause = "all", ttd_dist = "exponential", utility_model = "mixture")
tx_ihaq | Model structure relating treatment to HAQ during the first 6 months of treatment. Options, which are equivalent to H1-H3 in the documentation are:
|
---|---|
tx_iswitch | Model structure relating treatment to switching during the first 6 months of treatment. Options, which are equivalent to S1-S6 in the documentation are:
|
cdmards_haq_model | Model used for long-term HAQ progression. Options are:
If |
ttd_cause | Cause of treatment discontinuation. Options are:
|
ttd_dist | Distribution used to model time to treatment discontinuaton. Options are:
|
utility_model | Model used to estimate patient utility as a function of HAQ and patient characteristics. Options are:
|
mod.structs <- select_model_structures(tx_ihaq = c("acr-haq", "acr-eular-haq"), tx_iswitch = c("acr-switch", "acr-eular-switch"), cdmards_haq_model = c("lcgm", "linear"), ttd_cause = c("all", "si"), ttd_dist = c("gengamma", "exponential"), utility_model = c("mixture", "wailoo")) print(mod.structs)#> tx_ihaq tx_iswitch cdmards_haq_model ttd_cause #> [1,] "acr-haq" "acr-switch" "lcgm" "all" #> [2,] "acr-eular-haq" "acr-eular-switch" "linear" "si" #> ttd_dist utility_model #> [1,] "gengamma" "mixture" #> [2,] "exponential" "wailoo" #> attr(,"class") #> [1] "model_structures"